Left Bundle Branch Pacing for Cardiac Resynchronization Therapy: Nonrandomized On-Treatment Comparison With His Bundle Pacing and Biventricular Pacing

医学 射血分数 心脏病学 内科学 心脏再同步化治疗 捆绑 心脏起搏 心室起搏 心力衰竭 复合材料 材料科学
作者
Shengjie Wu,Lan Su,Pugazhendhi Vijayaraman,Rujie Zheng,Mengxing Cai,Lei Xu,Ruiyu Shi,Zhouqing Huang,Zachary I. Whinnett,Weijian Huang
出处
期刊:Canadian Journal of Cardiology [Elsevier]
卷期号:37 (2): 319-328 被引量:236
标识
DOI:10.1016/j.cjca.2020.04.037
摘要

Background Left bundle branch pacing (LBBP) is a novel method for delivering cardiac resynchronization therapy (CRT). We compared on-treatment outcomes with His bundle pacing (HBP) and biventricular pacing (BVP) in this nonrandomized observational study. Methods Consecutive patients with left-ventricular ejection fraction (LVEF) ≤ 40% and typical left bundle branch block (LBBB) referred for CRT received BVP, HBP, or LBBP. QRS duration, pacing threshold, LVEF, and New York Heart Association (NYHA) class were assessed. Results One hundred thirty-seven patients were recruited: 49 HBP, 32 LBBP, and 54 BVP; 2 did not receive CRT. The majority of patients had nonischemic cardiomyopathy. Mean paced QRS duration was 100.7 ± 15.3 ms, 110.8 ± 11.1 ms, and 135.4 ± 20.2 ms during HBP, LBBP, and BVP, respectively. HBP and LBBP demonstrated a similar absolute increase (Δ) in LVEF (+23.9% vs +24%, P = 0.977) and rate of normalized final LVEF (74.4% vs 70.0%, P = 0.881) at 1-year follow-up. This was significantly higher than in the BVP group (Δ LVEF +16.7% and 44.9% rate of normalized final LVEF, P < 0.005). HBP and LBBP also demonstrated greater improvements in NYHA class compared with BVP. LBBP was associated with higher R-wave amplitude (11.2 ± 5.1 mV vs 3.8 ± 1.9 mV, P < 0.001) and lower pacing threshold (0.49 ± 0.13 V/0.5 ms vs 1.35 ± 0.73 V/0.5 ms, P < 0.001) compared with HBP. Conclusion LBBP appears to be a promising method for delivering CRT. We observed similar improvements in symptoms and LV function with LBBP and HBP. These improvements were significantly greater than those seen in patients treated with BVP in this nonrandomized study. These promising findings justify further investigation with randomized trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
meng发布了新的文献求助10
刚刚
1秒前
Leon发布了新的文献求助10
1秒前
axunQAQ发布了新的文献求助10
1秒前
111发布了新的文献求助10
2秒前
3秒前
cc发布了新的文献求助10
6秒前
程勋航完成签到,获得积分10
6秒前
HH完成签到,获得积分10
6秒前
陆千万完成签到,获得积分10
8秒前
我是125应助老疯智采纳,获得10
8秒前
LEE发布了新的文献求助10
8秒前
Leon完成签到,获得积分10
11秒前
愉快的紫丝完成签到,获得积分10
11秒前
13秒前
玩命的紫南完成签到 ,获得积分10
14秒前
14秒前
14秒前
剁辣椒蒸鱼头完成签到 ,获得积分10
16秒前
牛牛要当院士喽完成签到,获得积分10
16秒前
16秒前
香蕉觅云应助lyt采纳,获得10
17秒前
WJ发布了新的文献求助10
18秒前
19秒前
dbq完成签到 ,获得积分10
19秒前
Owen应助reck采纳,获得10
21秒前
王淳完成签到 ,获得积分10
21秒前
22秒前
23秒前
高高的天亦完成签到 ,获得积分10
24秒前
追寻书白完成签到,获得积分20
25秒前
晚街听风完成签到 ,获得积分10
26秒前
26秒前
感觉他香香的完成签到 ,获得积分10
27秒前
27秒前
牛牛要当院士喽完成签到,获得积分10
27秒前
结实的老虎完成签到,获得积分10
29秒前
坚强丹雪完成签到,获得积分10
31秒前
33秒前
35秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527998
求助须知:如何正确求助?哪些是违规求助? 3108225
关于积分的说明 9288086
捐赠科研通 2805889
什么是DOI,文献DOI怎么找? 1540195
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709849